Abstract:Objective:To study the change of dose distribution by the change of the volume and morphology of the tumor and the normal tissues through the process of the nasopharyngeal carcinoma IMRT. Methods:All 42 patients who were pathologically diagnosed as nasopharyngeal carcinoma from January 2009 to June 2010 were admitted. All patients underwent a simulation CT before the treastment,and the images were uploaded to the Xio treatment therapy system( TPS). The target volume and normal tissues were contoured on the CT image and then the treatment IMRT plan was developed using 6MVX,9 coplanar fields. The dose to the nasopharyngeal tumor and lymph node was 66Gy/30f/6w,dose to the nasopharynx subclinical lesions and neck lymphatic drainage area was 60Gy/30f/6w. Daily or-thogonal images were acquired in the patient treatment position to compare with the DRR of the original treatment planning image,and the patient positionning error was corrected in three dimensions,then the radiation therapy was implemented. Each patient underwent a simulation CT scan weekly to analyse the dose distribution changes of the tar-get and the normal tissues. Concurrent chemotherapy regimen was cisplatin plus docetaxel every 3 weeks,the chemo-therapy was started before the beginning of the radiaotherapy. Results:The average volume of GTV1 was 39. 19cc be-fore radiotherapy,GTV2 was 16. 59cc,at 4th and 6th week of the radiotherapy course the average reduction of GTV1 were 26. 41%,62. 68%,for GTV2 were 28. 43%and 53. 93%respectively. Before treatment,the average volume of bi-lateral parotid was 24. 16cc,at 4th week of radiation therapy,the average volume of parotid was 19. 04cc,at 6th week the average volume of the parotid gland was 17. 54cc. For the does distribution to the normal tissues,in the original plan,spinal cord(D1%),brainstem(D1%),temporal lobe(D1%),the inner ear(Dmean),parotid gland(V30)are(41. 2 ± 0. 98)Gy,(51. 26 ± 1. 57)Gy,(59. 95 ± 2. 11)Gy,(45. 02 ± 1. 98)Gy,(47. 87 ± 18. 05)% respectively,at 4th week of radiotherapy,they are(44. 09 ± 1. 88)Gy,(52. 81 ± 2. 47)Gy,(62. 04 ± 2. 43)Gy,(47. 24 ± 3. 68)Gy, (49. 03 ± 15. 68)%,and at 6th week,(44. 44 ± 2. 7)Gy,(54. 14 ± 2. 51)Gy,(62. 34 ± 2. 86)Gy,(48. 37 ± 5. 37) Gy,(52. 19 ± 15. 51)%. Conclusion:In the nasopharyngeal IMRT process,the actual dose distribution of the tumor will be some difference to the original plan,except one case whose outline contour changes relatively sever because of the shrinkage of the lymph node and the weight loss,the CTV actual dose is above 95%of the prescribed dose,al-though after a few weeks of treatment the tumor target volume and shape changes,the difference was not significant. The dose to the normal tissues in the whole course of treatment will be increased compared with the original plan.

Changes of the Transverse Diameter and Volume and Dosimetry Before the 25th Fraction During the Course of Intensity-Modulated Radiation Therapy (imrt) for Patients with Nasopharyngeal Carcinoma

Clinical Study of the Necessity of Replanning Before the 25th Fraction During the Course of Intensity-Modulated Radiotherapy for Patients with Nasopharyngeal Carcinoma

Anatomic and Dosimetric Changes During the Treatment Course of Intensity-Modulated Radiotherapy for Locally Advanced Nasopharyngeal Carcinoma

SU‐FF‐T‐96: Clinical Study of the Necessity of Replanning IMRT Treatment for Patients with Nasopharyngeal Carcinoma

Is It Necessary to Repeat CT Imaging and Replanning During the Course of Intensity-Modulated Radiation Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma?

Impact of Anatomical Changes on Dose Distribution of Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma

Dosimetric Evaluation of Hippocampus Sparing Intensity Modulated Radiation Therapy in Patients with Stage T1-T2 and Stage T3-T4 Nasopharyngeal Carcinoma

Anatomical changes and dosimetric analysis of the neck region based on FBCT for nasopharyngeal carcinoma patients during radiotherapy

Impact of Reducing Clinical Target Volume on Efficacy of Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma

Using Neoadjuvant Chemotherapy and Replanning Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma with Intracranial Invasion to Protect Critical Normal Tissue

Dose-volume study for tumor and normal tissue of nasopharyngeal carcinoma with IMRT

Dose Deformation and Accumulation for Adaptive Radiotherapy in Nasopharyngeal Carcinoma

Prioritizing Sufficient Dose to Gross Tumor Volume over Normal Tissue Sparing in Intensity-Modulated Radiotherapy Treatment of T4 Nasopharyngeal Carcinoma.

Intensity-modulated carbon-ion radiation therapy versus intensity-modulated photon-based radiation therapy in locally recurrent nasopharyngeal carcinoma: a dosimetric comparison

Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series.

Will weight loss cause significant dosimetric changes of target volumes and organs at risk in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy?

Differences in Lower Cranial Nerve Complications Predicted by the NTCP Model Between RTOG and Reduced-Volume IMRT Planning in Radiotherapy for Nasopharyngeal Carcinoma

Dosimetric comparison of intensity modulated radiotherapy and intensity modulated proton therapy in the treatment of recurrent nasopharyngeal carcinoma

[Dosimetric Verification and Clinical Efficacy of Intensity Modulated Radiotherapy in Nasopharyngeal Carcinoma].

Dosimetric comparison with conventional radiation therapy and intensity modulated radiation therapy to nasopharyngeal carcinoma

Induction Chemotherapy Followed by Intensity-Modulated Radiotherapy with Reduced Gross Tumor Volume Delineation for Stage T3-4 Nasopharyngeal Carcinoma